GlassScriptPhysician profile
Heather Fishel
NPI 1487049300
$10,741.11
in general payments reported to CMS, 2019-2025
47 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $163 · 2021: $1,944 · 2022: $2,010 · 2023: $2,011 · 2024: $2,431 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,038 · Education: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,038.19 |
| Education | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,078.74 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,844.12 | 2020-2025 | Mounjaro, Jardiance, Lyumjev |
| Abbott Laboratories | $743.25 | 2019-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $662.49 | 2021-2025 | |
| Amgen INC. | $579.68 | 2021-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $442.84 | 2019-2024 | |
| Xeris Pharmaceuticals, INC. | $424.68 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Corcept Therapeutics | $332.11 | 2021-2025 | Korlym |
| Beta Bionics, INC. | $314.08 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Novartis Pharmaceuticals Corporation | $307.95 | 2023-2025 | |
| Insulet Corporation | $287.88 | 2021-2025 | Omnipod |
| Abbvie INC. | $245.61 | 2021-2025 | |
| Medtronic Minimed, INC. | $195.88 | 2019 | |
| Medtronic, INC. | $190.42 | 2021-2023 | Minimed 780g |
| Amneal Pharmaceuticals LLC | $181.96 | 2021-2024 | Unithroid |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $180.24 | 2021-2023 | Farxiga |
| Radius Health, INC. | $174.36 | 2021-2024 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.91 | 2021-2025 | Jardiance |
| Tandem Diabetes Care, INC. | $140.25 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $107.99 | 2021-2025 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $101.49 | 2022 | |
| Rochester Medical Corporation | $92.94 | 2021 | |
| Esperion Therapeutics, INC. | $75.45 | 2021-2025 | Nexletol |
| Melinta Therapeutics, LLC | $75.06 | 2022 | |
| Lifescan, INC. | $69.97 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $64.17 | 2021-2023 | |
| Recordati_rare_diseases_inc. | $62.46 | 2022-2025 | Isturisa, Signifor Lar |
| Sequel Med Tech, LLC | $60.12 | 2025 | Twiist |
| Rhythm Pharmaceuticals, INC. | $53.82 | 2025 | Imcivree |
| Actelion Pharmaceuticals US, INC. | $49.52 | 2020-2021 | |
| Horizon Therapeutics Plc | $47.44 | 2020-2023 | Tepezza |
| Alexion Pharmaceuticals, INC. | $41.56 | 2023 | Strensiq |
| Ibsa Pharma INC. | $41.23 | 2023-2024 | Tirosint, Tirosint, Licart |
| Pfizer INC. | $35.53 | 2023-2024 | |
| Nevro Corp. | $32.60 | 2022 | |
| Ascendis Pharma Endocrinology INC | $32.52 | 2025 | Yorvipath |
| Kyowa Kirin, INC. | $31.79 | 2023-2024 | Crysvita |
| Neurocrine Biosciences, INC. | $24.04 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $23.28 | 2021 | |
| Glaxosmithkline, LLC. | $22.75 | 2025 | Shingrix, Arexvy |
| Chiesi USA, INC. | $22.29 | 2024 | Mycapssa |
| Eusa Pharma (US) LLC | $21.30 | 2022 | |
| Astellas Pharma US INC | $18.34 | 2025 | Veozah |
| Vistapharm, INC. | $16.57 | 2021 | |
| Antares Pharma, INC. | $15.79 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.36 | 2025 | Belbuca |
| Averitas Pharma INC. | $15.28 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Fishel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.